Unverricht-Lundborg Disease
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
CSTB,
SCARB2,
PRICKLE1,
KCTD7,
ASAH1,
GOSR2,
EPM2A,
PFKL,
EJM2,
BSCL2,
LSM2,
TBC1D24,
STX5,
TFF1,
TRAPPC10,
U2AF1,
LMNB2,
DHX40,
CDK5R1,
SEC22B,
CARS2,
BET1,
TPPP,
PADI4,
SACS,
SMN2,
TMPRSS3,
TMED9,
CLN6,
SNAP25
CSTB,
SCARB2,
PRICKLE1,
KCTD7,
ASAH1,
GOSR2,
EPM2A,
PFKL,
EJM2,
BSCL2,
LSM2,
TBC1D24,
STX5,
TFF1,
TRAPPC10,
U2AF1,
LMNB2,
DHX40,
CDK5R1,
SEC22B,
CARS2,
BET1,
TPPP,
PADI4,
SACS,
SMN2,
TMPRSS3,
TMED9,
CLN6,
SNAP25,
AIRE,
SMN1,
KCNC1,
BCL2,
CACNA1A,
CHRNA4,
COL6A2,
CST3,
GSTA1,
GSTT1,
HPE1,
HRES1,
ITGB2,
KCNQ2,
ARSA,
KCNQ3,
LCN2,
LMNA,
LY6E,
MECP2,
NEU1,
SERPINI1,
PRNP,
PWP2,
ATXN2,
SCN1A
Drugs
Registered!
Unverricht-Lundborg disease (ULD) is a rare progressive myoclonic epilepsy disorder characterized by action- and stimulus-sensitive myoclonus, and tonic-clonic seizures with ataxia, but with only a mild cognitive decline over time.